Graney & King’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Hold
202
0.1% 73
2025
Q4
$217K Buy
202
+20
+11% +$19.1K 0.13% 62
2025
Q3
$138K Buy
182
+1
+0.6% +$744 0.1% 78
2025
Q2
$141K Buy
181
+23
+15% +$17.9K 0.09% 76
2025
Q1
$131K Buy
158
+13
+9% +$10.8K 0.1% 71
2024
Q4
$112K Buy
+145
New +$120K 0.08% 79

Other funds holding LLY

Graney & King's LLY Position: Q1 2026 in Review

Graney & King held its Eli Lilly (LLY) position steady in Q1 2026 at 202 shares worth $186K. The position accounts for 0.1% of the portfolio, ranked #73.

Graney & King first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $217K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Graney & King held 202 shares of Eli Lilly worth $186K as of Q1 2026.
  • Graney & King left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.1% of Graney & King's portfolio in Q1 2026, its #73 holding.
  • Graney & King first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Graney & King's Eli Lilly position peaked at $217K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.